=====================================================================
The 11th International Workshop on Vaccines and Drug Ontology Studies (VDOS-2022)
https://sites.google.com/view/vdosworkshop/vdos-2022
=====================================================================
Hybrid (In-person and virtual meeting)
Half-day workshop in conjunction with the
The 13th International Conference on Biomedical Ontology (ICBO 2022)
(25 - 28 September 2022; Hybrid event at Ann Arbor, MI and virtual)
Paper Submission Deadline: June 24, 2022
Workshop Theme and Topics
Drugs and vaccines have contributed to dramatic improvements in public health worldwide. Over the last decades, there have been efforts in the biomedical ontology community that represents various areas associated with drugs including vaccines that extend existing health and clinical terminology systems (e.g., SNOMED, RxNorm, NDF- RT, and MedDRA), vernacular medical terminologies, and their applications to research and clinical data.
This workshop will provide a platform for discussing innovative solutions as well as the challenges in the development and application of biomedical ontologies to representing and analyzing drugs and vaccines, their administration, immune responses induced, adverse events, and similar topics. The workshop will cover two main areas: (i) ontology representation of vaccines, drugs, and vaccine/drug-related domains (e.g., adverse events), and (ii) applications of the ontologies in real-world situations – administration, adverse events, etc. Examples of biomedical subject matter in the scope of this workshop: drug components (e.g., drug active ingredients, vaccine antigens, and adjuvants), administration details (e.g., dosage, administration route, and frequency), gene immune responses and pathways, drug-drug or drug-food interactions, and adverse events. Both research and clinical subjects will be covered. We will also focus on computational methods used to study these, for example, literature mining of vaccine/drug-gene interaction networks, pathway analysis, meta-analysis of host immune responses, and time event analysis of the pharmacological effects.
We encourage submissions related to the COVID-19 pandemic. Drugs and vaccines are critical to fighting against COVID-19. We welcome papers in the domain of drugs and vaccines against COVID-19.
Submission Guidelines
For the paper submission, we will allow three submission formats:
The paper format will be the same as the format used in ICBO.
The paper format will be the same as the format used in ICBO. Contributions must be delivered non-anonymously and as a single PDF file. The CEUR-WS single and double column formatting guidelines can be found at http://ceur-ws.org/Vol-XXX/CEURART.zip. The direct template download for Latex and MS Word is available here: http://ceur-ws.org/Vol-XXX/CEURART.zip. There is also an Overleaf Template available here: https://www.overleaf.com/latex/templates/template-for-submissions-to-ceur-workshop-proceedings-ceur-ws-dot-org/hpvjjzhjxzjk.
All the papers will be submitted and handled through EasyChair: https://easychair.org/conferences/?conf=vdos2022
We will automatically send the accepted papers to the main ICBO conference organizers so that the abstract can be included in the proceedings. The presenters of the accepted papers are also expected to give a poster presentation at the main conference.
After the full papers are accepted, we will work with the BMC Bioinformatics editors and reviewers to decide which papers will be formally invited for an extension to be included in a thematic series in the BMC Bioinformatics journal. All full-length (6-8 pages) and short-length (2-3 pages) submissions will go through peer reviews by at least two reviewers. The one-page statement-of-interest submissions will be reviewed by the workshop organizers.
Important Dates
Organizers
Program Committee (PC) Members
Contact
If you have any questions or wish to inquire about the workshop, please contact:
**********************************************************
Electronic Mail is not secure, may not be read every day, and should not be used for urgent or sensitive issues
=====================================================================
The 12th International Workshop on Vaccines and Drug Ontology Studies (VDOS-2023)
=====================================================================
Hybrid (In-person and virtual meeting)
Half-day workshop in conjunction with the
The 14th International Conference on Biomedical Ontology (ICBO 2023)
Held with the 16th Seminar on Ontology Research in Brazil (ONTOBRAS)
(August 28 - September 01, 2023; Brasilia, Brazil)
Paper Submission Deadline: June 30, 2023
Workshop Theme and Topics
Drugs and vaccines have contributed to dramatic improvements in public health worldwide. Over the last decades, there have been efforts in the biomedical ontology community that represents various areas associated with drugs including vaccines that extend existing health and clinical terminology systems (e.g., SNOMED, RxNorm, NDF-RT, and MedDRA), vernacular medical terminologies, and their applications to research and clinical data.
This workshop will provide a platform for discussing innovative solutions as well as the challenges in the development and application of biomedical ontologies to representing and analyzing drugs and vaccines, their administration, immune responses induced, adverse events, and similar topics. The workshop will cover two main areas: (i) ontology representation of vaccines, drugs, and vaccine/drug-related domains (e.g., adverse events), and (ii) applications of the ontologies in real-world situations – administration, adverse events, etc. Examples of biomedical subject matter in the scope of this workshop: drug components (e.g., drug active ingredients, vaccine antigens, and adjuvants), administration details (e.g., dosage, administration route, and frequency), gene immune responses and pathways, drug-drug or drug-food interactions, and adverse events. Both research and clinical subjects will be covered. We will also focus on computational methods used to study these, for example, literature mining of vaccine/drug-gene interaction networks, pathway analysis, meta-analysis of host immune responses, and time event analysis of the pharmacological effects.
We encourage submissions related to the COVID-19 pandemic using ML/AI approaches. Drugs and vaccines are critical to fighting against COVID-19. We welcome papers in the domain of drugs and vaccines against COVID-19.
Submission Guidelines
For the paper submission, we will allow three submission formats:
The paper format will be the same as the format used in ICBO.
All full-length papers and selected short papers will be invited to submit a full revised version to the journal of biomedical semantics (JBMS) VDOS Special Issue.
The paper format will be the same as the format used in ICBO. Contributions must be delivered non-anonymously and as a single PDF file, following the CEUR-ART template.docx file (https://www.icbo2023.ncor-brasil.org/papers/CEUR-Template-1col.docx), single column. Microsoft Office Word, Open Office and LaTeX templates can be downloaded at CEURART.zip (https://www.icbo2023.ncor-brasil.org/papers/CEURART.zip) or direct from CEUR (http://ceur-ws.org/Vol-XXX/CEURART.zip).
There is also an Overleaf Template available here: https://www.overleaf.com/latex/templates/template-for-submissions-to-ceur-workshop-proceedings-ceur-ws-dot-org/hpvjjzhjxzjk
All the papers will be submitted and handled through EasyChair: https://easychair.org/my/conference?conf=vdos2023
We will automatically send the accepted papers to the main ICBO conference organizers so that the abstract can be included in the proceedings. The presenters of the accepted papers are also expected to give a poster presentation at the main conference.
All full-length (6-8 pages) and short-length (2-3 pages) submissions will go through peer reviews by at least two reviewers. The one-page statement-of-interest submissions will be reviewed by the workshop organizers.
Important Dates
Organizers
Contact
If you have any questions or wish to inquire about the workshop, please contact:
Program Committee (PC) Members
**********************************************************